# THE IMPACT- 24M TRIAL (IMPlant Augmenting Cerebral Blood Flow in Mild Strokes Trial 24 Hours From Stroke Onset)

> **NCT03551093** · NA · COMPLETED · sponsor: **BrainsGate** · enrollment: 50 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DEVICE:** ISS SPG stimulation

## Key facts

- **NCT ID:** NCT03551093
- **Lead sponsor:** BrainsGate
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-02
- **Primary completion:** 2018-09-11
- **Final completion:** 2018-09-11
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2019-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03551093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03551093, "THE IMPACT- 24M TRIAL (IMPlant Augmenting Cerebral Blood Flow in Mild Strokes Trial 24 Hours From Stroke Onset)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03551093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*